Opinion
Video
Panelists talk about how affected person involvement in a number of myeloma therapy selections has advanced from a physician-directed strategy to a collaborative partnership, with many sufferers now actively collaborating by way of researching choices, becoming a member of assist teams, asking questions on efficacy and uncomfortable side effects, and dealing with their well being care crew to stability high quality of life issues with therapy objectives, although the diploma of engagement varies based mostly on affected person desire, well being literacy and doctor communication model.
Video content material above is prompted by the next:
- How concerned have you ever been within the decision-making course of on your therapy plan?
